JONATHAN REECE: Open Payments
NPI 1871038232 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,070 in 41 payments from 8 companies in 2025. Trend: 2023 $616 · 2024 $589 · 2025 $1,070
Food & beverage: $1,070
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 10 | $313 |
| E.R. Squibb & Sons, L.L.C. | 11 | $244 |
| Janssen Pharmaceuticals, Inc | 5 | $164 |
| Alkermes, Inc. | 5 | $122 |
| Neurocrine BioSciences, Inc. | 3 | $81 |
| Teva Pharmaceuticals USA, Inc. | 3 | $65 |
| Collegium Pharmaceutical, Inc. | 2 | $48 |
| Supernus Pharmaceuticals, Inc. | 2 | $33 |
Products named: COBENFY, ABILIFY ASIMTUFII, INVEGA SUSTENNA, ARISTADA, REXULTI, INGREZZA, UZEDY, Jornay PM.
Industry payments across NY — which companies pay providers there.
